Landos Biopharma

Landos Biopharma is dedicated to the research and development of novel drugs for combating autoimmune diseases. Landos' lead candidate drug, BT-11, is the first orally active and locally effective new drug, which can be used to treat Crohn's disease and ulcerative colitis.